In this webinar sponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs, Kelly Young-Wolff, PhD, MPH (a licensed clinical psychologist and research scientist at the Kaiser Permanente Northern CA Division of Research) will describe what is known about prenatal cannabis use trends and health consequences using data from Kaiser Permanente Northern California’s large integrated healthcare delivery system. She will discuss why pregnant individuals use cannabis, describe disparities in prenatal cannabis use and related outcomes, and end with a discussion about the potential harms of punitive policies that penalize or criminalize prenatal substance use. At the conclusion of the webinar, participants will be able to: Describe at least two (2) trends relating to changing rates of prenatal cannabis use over time. Explain at least three (3) reasons why pregnant individuals might be using cannabis. Specify at least three (3) potential risks of using cannabis during pregnancy. 1.5 CME or CE credits available! (Select credit type when you register; learn more about available credit types here.) Sponsored by the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) and the Western States Node of the NIDA Clinical Trials Network.

The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual Quarterly Steering Committee Meeting on Tuesday, March 11, 2025 from 1:00 – 5:00 p.m. ET. 

Successful implementation and sustainment of interventions is heavily influence by context. Yet the complexity and dynamic nature of context make it challenging to connect and translate findings across implementation efforts, limiting potential replicability and utility. The Inventory of Factors Affecting Successful Implementation and Sustainment (IFASIS) was developed to be a pragmatic, quantitative, organizational-level assessment of contextual factors. The intention is to characterize context with a measure that may enhance replication and reproducibility of findings beyond single implementation case studies. In this talk, the development and validation of the IFASIS will be presented, as well as examples of its practical utility. Speaker: Helene Chokron Garneau, PhD, MPH (Senior Research Scientist at Stanford University School of Medicine and co-Director of the Center for Dissemination and Implementation At Stanford (C-DIAS). To join the session, contact Elena Rosenberg-Carlson at rosenbee@stanford.edu

The Annual CPDD meeting for 2025 will be held June 14-18, 2026 in New Orleans, LA.